Brandi Glanville Removes Black Mass

1/3

•6m ago

Brandi Glanville Removes Black Mass

Tap title to read story

0:00 / 0:45

Brandi Glanville, 53, revealed on her Unfiltered podcast that doctors removed a “black mass” from her face during a recent surgical procedure. She explained that the mass was one of several removed and that its nature remains unknown. Glanville is battling an antibiotic‑resistant infection in her glands and is on antibiotics almost 24 hours a day, though she has seen some improvement with new medications. She also has a range of conditions, including Demodex dermatitis, mononucleosis, Valley Fever, and highly resistant Klebsiella and Enterobacter infections. The surgery was described as exploratory, with the surgeon using a power washer, knives, and other instruments to investigate possible fungal balls or other live tissue. She first began experiencing symptoms in 2023 and has since undergone multiple treatments to manage her complex medical situation.

Published 2026-11-15 06:10:43 UTC · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Timeline

On January 1 2023 Glanville first experienced facial symptoms.
On November 14 2026 Doctors removed black mass during surgery.
On November 14 2026 Glanville shared surgery details on podcast.

Why it matters

Immediate US impact: No direct economic impact reported Possible long-term US impact: No long‑term economic impact identified Most affected groups: Medical professionals and patients with resistant infections Reader priority: High interest for fans and health‑aware audiences

Coverage notes

Center: Coverage from dailymail.com, imdb.com, usmagazine.com frames this as a developing news story: Brandi Glanville Removes Black Mass. Reporting emphasizes verified facts, named sources, and near-term impact for readers. Left: Left-leaning desks covering the same development typically emphasize public impact, institutional accountability, and who is most affected. Right: Right-leaning desks covering the same development typically emphasize practical outcomes, market or security stakes, and institutional response.